Pfizer Agrees To Let Other Companies Manufacture Its COVID-19 Pill

Pfizer Agrees To Let Other Companies Manufacture Its COVID-19 Pill

Assessment

Interactive Video

Other

University

Hard

Created by

Wayground Content

FREE Resource

The video discusses a COVID-19 pill that could be available to over half the world's population. The pharmaceutical company will not charge royalties in low-income countries and will waive them where COVID-19 remains a public health emergency. The pill reportedly reduces hospitalization and death by 90% in mild and moderate cases. The company is awaiting federal authorization.

Read more

5 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the potential impact of the COVID-19 pill on global treatment availability?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What stance does Visor take regarding royalties in low-income countries?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

In what context is the term 'public health emergency' mentioned?

Evaluate responses using AI:

OFF

4.

OPEN ENDED QUESTION

3 mins • 1 pt

How much does the pill reduce hospitalization and death rates in mild and moderate cases?

Evaluate responses using AI:

OFF

5.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the current status of the pharmaceutical company's federal authorization?

Evaluate responses using AI:

OFF